{"id":1968,"date":"2025-12-22T11:08:28","date_gmt":"2025-12-22T02:08:28","guid":{"rendered":"https:\/\/lmi.jp\/articles\/?p=1968"},"modified":"2026-06-30T10:53:45","modified_gmt":"2026-06-30T01:53:45","slug":"effects-of-assigning-a-risk-manager-in-the-clinical-laboratory-on-the-management-of-critical-values-at-tohoku-medical-and-pharmaceutical-university-hospital","status":"publish","type":"post","link":"https:\/\/lmi.jp\/articles\/2025\/12\/22\/effects-of-assigning-a-risk-manager-in-the-clinical-laboratory-on-the-management-of-critical-values-at-tohoku-medical-and-pharmaceutical-university-hospital\/","title":{"rendered":"Effects of Assigning a Risk Manager in the Clinical Laboratory on the Management of Critical Values at Tohoku Medical and Pharmaceutical University Hospital"},"content":{"rendered":"\n

Ririka Miura<\/strong><\/a>*1<\/sup>, Rikei Kozakai<\/strong><\/a>*1<\/sup>, Yasuhiro Endo<\/strong><\/a>, MD, PhD*1,2<\/sup>, \u2020Shinichiro Takahashi<\/strong><\/a>, MD, PhD *1,2<\/sup><\/p>\n\n\n\n

\n
\u2003 Cite<\/span><\/span><\/i><\/i><\/span><\/summary>
\n

Miura R, Kozakai R, Endo Y, Takahashi S. Effects of Assigning a Risk Manager in the Clinical Laboratory on the Management of Critical Values at Tohoku Medical and Pharmaceutical University Hospital. Lab Med Int 2025; 4(4): 125-131. doi: 10.51041\/lmi.4.4_125<\/p>\n<\/div><\/details>\n<\/div>\n\n\n\n

Short Communication
Lab Med Int 2025; 4(4): 125-131<\/p>\n\n\n\n

\u2020\u0007Correspondence: Division of Laboratory Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 1-15-1 Fukumuro, Miyagino-ku, Sendai 983-8536, Japan
Tel: +81-22-290-8889; Fax: +81-22-290-8889;
E-mail: shintakahashi”@”tohoku-mpu.ac.jp
Received May 20, 2025; accepted August 19, 2025
*1 \u0007Department of Clinical Laboratory, Tohoku Medical and Pharmaceutical University Hospital, 1-12-1 Fukumuro, Miyagino-ku, Sendai 983-8512, Japan
*2 \u0007Division of Laboratory Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 1-15-1 Fukumuro, Miyagino-ku, Sendai 983-8536, Japan<\/span><\/strong><\/p>\n\n\n\n

Download PDF<\/span><\/a><\/div>\n\n\n\n

ABSTRACT<\/strong><\/h2>\n\n\n\n

Objective:<\/strong> Effective management of medical treatment information, particularly critical values, is essential in every clinical laboratory. A proposal for the management of critical values was issued by the Japanese Society of Laboratory Medicine in 2021. Our laboratory began implementing the revised proposal in December 2024, which recommends appointing a medical technologist as a risk manager. The risk manager is responsible for monitoring the occurrence of critical values, and acting as a liaison between the Clinical Laboratory and the Medical Safety Department.
Methods:<\/strong> We evaluated the impact of sharing and reviewing critical values, by a risk manager, with the Medical Safety Department by analyzing the number and content of critical value reports and tracking telephone communications from laboratory physician to attending physicians. Data from the fiscal year 2018 through June 2025 were included in the analysis.
Results:<\/strong> In our hospital, the total number of tests increased from 2,301,813 in 2018 to 3,235,049 in 2024. Between April 2018 and November 2024, there were 10 telephone calls from laboratory physician to attending physicians regarding 28,980 critical values. In contrast, from December 2024 onward, there were 13 such calls for just 2,495 critical values\u2013\u2013a statistically significant increase (z = \u20138.65, p < 0.0001) following the appointment of a risk manager.
Conclusions:<\/strong> The introduction of a risk manager to facilitate the sharing and review of critical values with the Medical Safety Department led to a significant increase in follow-up telephone communication from laboratory physician. This may reflect improved professional oversight and laboratory management.<\/p>\n\n\n\n

\u3014Lab Med Int 2025; 4(4): 125-131\u3015<\/p>\n\n\n\n

Key Words<\/strong><\/h3>\n\n\n\n

critical value, risk management, medical safety<\/p>\n\n\n\n

I. Introduction<\/strong><\/h2>\n\n\n\n

In clinical laboratories, the frequency of errors is considered to be lower than in other hospital departments. However, even a low error rate can still result in a considerable number of incidents due to the large volume of tests performed daily1)<\/strong><\/sup>. Therefore, ensuring medical safety is essential not only in high-risk areas but also in all departments, including clinical laboratories. The 2007 medical service law required medical institutions to prepare guidelines for various aspects of hospital operation, including maintenance plans for medical equipment, procedures for pharmaceutical use, infection control, and importantly, medical safety2)<\/strong><\/sup>. As a result, medical safety guidelines are now seen as necessary tools to support the delivery of accurate and reliable clinical laboratory data to physicians, and efforts to enhance medical safety have attracted growing attention3)4)<\/strong><\/sup>.
Our laboratory, the Department of Clinical Laboratory at Tohoku Medical and Pharmaceutical Hospital, obtained ISO 15189 accreditation in January 20195)<\/strong><\/sup>. Thereafter, we experienced, and reported in this journal, that the implementation of ISO 15189 led to a significant improvement in risk management, contributing to enhanced medical safety and a reduction in the number of incidents6)7)<\/strong><\/sup>.
In 2021, the Japanese Society of Laboratory Medicine issued a proposal for managing critical values, which was revised in 20248)<\/strong><\/sup>. Our laboratory, started following the proposal for critical values from December 2024, which recommends to appoint a medical technologist as a risk manager to monitor the number of critical values occurred, review and act as a conduit between Clinical Laboratory, and Medical Safety Department. We report here, the significant increment of checking telephone call from laboratory physician, which may reflect more professional laboratory management.<\/p>\n\n\n\n

II. Methods<\/strong><\/h2>\n\n\n\n

A. Participants and statistics<\/strong>
We analyzed the number of critical values that occurred in the Department of Clinical Laboratory at Tohoku Medical and Pharmaceutical University Hospital. The definition of critical values used in this hospital followed the criteria described previously9)<\/strong><\/sup>. The number of critical values observed during the study period was 28,980 from April 1, 2018 to November 30, 2024, and 2,495 from December 2024 to June 30, 2025. For statistical analysis, a z-test was performed to evaluate the significance of differences, and statistical significance was determined accordingly. <\/p>\n\n\n\n

B. Ethics<\/strong>
We carefully considered the protection of personal information. This study focused exclusively on the number of tests and critical values, and did not involve any patient-identifiable data. We strictly adhered to the Policy on the Handling of Case Reports issued by the Ethics Committee of Tohoku Medical and Pharmaceutical University Hospital. <\/p>\n\n\n\n

III. Results<\/strong><\/h2>\n\n\n\n

1. Transition of the number of the critical values and critical values commenting reports<\/em><\/strong>
Our hospital has undergone several transitions over the years. In 2013, it changed its name from Tohoku Welfare Pension Hospital to Tohoku Pharmaceutical University Hospital (466 beds). Following the establishment of the medical faculty in 2016, the hospital was renamed Tohoku Medical and Pharmaceutical University Hospital. The number of beds increased to 600 in 2020. In this way, the hospital has gradually evolved from a community hospital to a university hospital, with a unique background and changing roles and functions. Annual changes in the total number of tests (including both specimen and physiological tests) during the study period are shown in Figure 1<\/strong>. The actual numbers were as follows (by fiscal year): 2018: 2,301,813, 2019: 2,545,856, 2020: 2,670,728, 2021: 2,906,752, 2022: 2,873,229, 2023: 2,931,994, 2024: 3,235,049. Overall, the number of tests increased approximately 1.4-fold during this period. 
The management of critical values in our laboratory is carried out as follows. Critical values9<\/strong>)<\/sup> are reported through the electronic medical record system and by telephone calls from medical technologists to the physicians who ordered the test. All reports are documented in forms called \u201cphone call record memos\u201d (S Figure 1<\/strong>). The laboratory physician checks these memos several times a day and confirms, through the electronic medical records, whether the attending physician has taken any action regarding the critical value. If no action is observed in response to a critical value involving antibiotic-resistant bacteria, the laboratory physician issues a \u201ccritical values commenting report.\u201d For other types of critical values, if no action is taken, the laboratory physician directly calls the attending physician and issues a \u201ccritical values commenting report\u201d if necessary (S Figure 2<\/strong>).
Until June 2020, the number of critical value items was extremely high at 64 (national average: 19.9)9)<\/strong><\/sup>, and approximately 7,000 reports of critical values were made annually via telephone (national average: 2,472)9)<\/strong><\/sup>. Therefore, a review of the critical value reporting criteria was conducted to ensure appropriate operation. In June 2020, the definition of critical values was revised, reducing the number of items by 1810)<\/strong><\/sup>, which clearly led to a decrease in daily reported critical values.
Annual changes in the number of critical values, categorized by medical service, are shown in Figure 2<\/strong>. The number of annual critical values clearly decreased after 2020. After June 2020, most of the \u201ccritical values commenting reports\u201d were related to antibiotic-resistant bacteria, and their numbers gradually declined (S Figure 3<\/strong>). This may indicate that documentation of pathogens in electronic medical records by the attending physicians has become standardized, thereby reducing the need for laboratory physician to issue these reports frequently.
As shown in Figure 3<\/strong>, before June 2020, roughly 30 to 40 critical values were reported daily. After the revision in June 2020, the number decreased to about 10 to 20 per day. During the period from April 2018 to November 2024, the number of checking telephone calls made by laboratory physician was 10 (out of 28,980 critical values), whereas after December 2024, when appointed a medical technologist as a risk manager to monitor the number of critical values, the number increased to 13 (out of 2,495). Notably, the proportion of such calls increased significantly, with statistical significance (z = \u20138.65, p < 0.0001). <\/p>\n\n\n\n

2. Transition of the checking telephone call from laboratory physician<\/em><\/strong>
As noted in the Introduction, in December 2024, we appointed a medical technologist as a risk manager to monitor the number of critical values, conduct reviews, and act as a conduit between the Clinical Laboratory and the Medical Safety Department. The details of a phone call from 2018 are described in Table 1<\/strong> (S Figure 4<\/strong>). Among the confirmation calls made by laboratory physician during this period, those concerning potassium concentration (n=8) were the most frequent. Other calls were related to white blood cell morphology and\/or counts (n=4), platelet number (n=3), possible M-protein (n=2), flow cytometry results (n=2), coagulation and fibrinolysis (n=2), blood glucose levels (n=1), and antibiotic-resistant bacteria (n=1). Among these calls, on February 18, 2020, we encountered a case in which the laboratory physician contacted the attending physician, who was unaware of a critically low platelet count (Plt = 6,000\/\u03bcL). This occurred because, laboratory technologists typically notify the physician who ordered the test. However, in this instance, the attending physician differed from the ordering physician, and the notification failed to reach the appropriate recipient. In May 2025, serum protein electrophoresis revealed a possible M-protein in a patient managed by a resident physician in a certain department. Although the resident had been informed of the result, they were uncertain about the appropriate next steps, and no follow-up action was taken. The following day, the laboratory physician contacted the resident, advising additional diagnostic orders and referral to hematology, which subsequently led to a diagnosis of multiple myeloma. A similar incident occurred again in June. These cases suggest that a certain proportion of phone calls made by laboratory physicians may indeed contribute to patient safety. Therefore, the confirmation calls made by laboratory physician serve as a final safeguard. <\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Figure 1<\/strong> Annual changes of the transition of the total number of tests<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Figure 2 <\/strong>Transition of the number of the critical values.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Figure 3<\/strong> Transition of the number of the critical values, critical values commenting reports and checking telephone
call from laboratory physician.<\/p>\n\n\n\n

IV. Discussion<\/strong><\/h2>\n\n\n\n

The definition of critical values has been debated by laboratory professionals for decades11)<\/strong><\/sup>. Lippi et al. summarized recommendations regarding the notification, parameters, and communication of critical laboratory values based on available guidelines from the Joint Commission, Clinical and Laboratory Standards Institute, and the Royal College of Pathologists12)<\/strong><\/sup>. Although there is some agreement on the definition of critical values, they remain relatively heterogeneous worldwide12)<\/strong><\/sup>, and no universally accepted definition or list of parameters exists. They are typically defined locally in agreement with relevant stakeholders.
In this context, Doering et al. examined five years of inpatient admissions for critical or near-critical results. They found that elevated potassium thresholds effectively identified patients at risk of death. Furthermore, they clarified that the mortality risk associated with most critical values is time-dependent13)<\/strong><\/sup>. Murakami et al. investigated the importance of various clinical test items (glucose, BUN, sodium, potassium, AST, ALT, LDH, CK, phosphate, calcium, serum amylase, white blood cell count, hemoglobin, platelets, PT-INR) by conducting a questionnaire survey among physicians. They found that abnormal results for glucose, PT-INR, and potassium concentration were most frequently regarded as \u201ccritical values requiring immediate medical intervention\u201d14)<\/strong><\/sup>. In our study, among the checking calls made by laboratory physician, those related to potassium concentration were the most frequent (Table 1<\/strong>). Therefore, it may be necessary to handle results for potassium, glucose, and PT-INR with particular care, ensuring that prompt action is taken by the attending physicians. Further attention and improvement in the communication of these critical values are essential for enhancing medical safety.
It should be noted that various factors can affect serum potassium levels, including elevated white blood cell or platelet counts and pre-analytical factors such as hemolysis or delayed centrifugation during specimen processing15)<\/strong><\/sup>. Therefore, laboratory staff should always consider these factors and may need to provide guidance on interpreting such results.
Several studies have shown that multidisciplinary collaboration is necessary to ensure that all critical values are responded to appropriately. One report indicated that in the intensive care unit (ICU), implementation of a daily goals form\u2014which enhanced communication among nurses and residents\u2014reduced ICU length of stay from a mean of 2.2 days to 1.1 day16)<\/strong><\/sup>. Fazzini et al. also emphasized the value of regular multidisciplinary safety briefings, which improved situational awareness and nearly halved delays in critical care referrals17)<\/strong><\/sup>.
In conclusion, sharing and reviewing critical values with the Medical Safety Department through a designated risk manager led to a significant increase in checking telephone calls from laboratory physician. This may reflect a more professional approach to laboratory management.<\/p>\n\n\n\n

Funding<\/strong>
This work was supported in part by the Shino-Test Corporation and the Shionogi Corporation Research Fund.<\/p>\n\n\n\n

Author contributions<\/strong>
R. Miura, played a pivotal role for this study, as a risk manager to monitor the critical value, acting as a liaison between our laboratory and medical safety department. R. Miura also analyzed the data and designed the figures. R. Kozakai contributed to manage critical value reporting system. Y. Endo analyzed the data. S. Takahashi designed the study and wrote the manuscript. All authors have accepted responsibility for the entire content of this manuscript and have approved its submission.<\/p>\n\n\n\n

Disclosure of Conflicts of Interest <\/strong>
None<\/p>\n\n\n\n

Table 1<\/strong> Details of telephone call from laboratory physician<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

References<\/strong><\/h2>\n\n\n\n
    \n
  1. Kalra J. Medical errors: impact on clinical laboratories and other critical areas. Clin Biochem. 2004; 37(12): 1052-62.PubMed<\/a><\/span>\n<\/li>\n\n\n\n
  2. Outline of revised health care law. Enforced on April, 2007. Downloaded from\u3008https:\/\/www.mhlw.go.jp\/shingi\/2007\/11\/dl\/s1105-2b.pdf<\/strong><\/a>\u3009\uff08accessed on Dec30, 2024\uff09 <\/li>\n\n\n\n
  3. Tsunekawa K, Asai Y, Ikegami S, et al. Incident analysis and preventive measures taken in the general laboratory of hospital. Jap J Med Tech. 2019; 68(2): 333-38.J-STAGE<\/a><\/span>\n<\/li>\n\n\n\n
  4. Maeda F, Izumi S, Nakanishi H, et al. Efforts of inspection technology department and medical safety management committee: Incident accident report, positive report, fiscal year safety target. Jap J Med Tech. 2017; 66(4): 404-10.<\/li>\n\n\n\n
  5. Ohba Y, Kozakai R, Izumi Y et al. Efforts to Gain Accreditation for ISO 15189 in the Department of Clinical Laboratory, Tohoku Medical and Pharmaceutical University Hospital. Rinsho Byori. 2018; 66(12): 1341-47.<\/li>\n\n\n\n
  6. Miura R, Kozakai R, Suzuki S, et al., Analysis of Incident\/Accident Reports in the Department of Clinical Laboratory at Tohoku Medical and Pharmaceutical University Hospital: Effect of ISO 15189 Implementation on Medical Safety. Lab Med Int. 2024; 3(1): 8-14. J-STAGE<\/a><\/span>\n<\/li>\n\n\n\n
  7. Miura R, Kozakai R, Takahashi S. The effect of ISO 15189 implementation for the reduction of incidents.<\/strong><\/a> Lab Med Int. 2024; 3(2): 26-7. <\/li>\n\n\n\n
  8. Japanese Society of Laboratory Medicine. Proposal for the management of critical values. Downloaded from\u3008https:\/\/www.jslm.org\/committees\/team_med\/20240610-1.pdf<\/strong><\/a>\u3009\uff08accessed on Jan 1, 2025\uff09.<\/li>\n\n\n\n
  9. Japanese Society of Laboratory Medicine. National critical value survey 2017. Downloaded from \u3008https:\/\/www.jslm.org\/committees\/team_med\/panic_2017.pdf<\/strong><\/a>\u3009\uff08accessed on Apr 24, 2025\uff09<\/li>\n\n\n\n
  10. Kozakai R, Takahashi S. How can we deal with critical values? From the laboratory in major hospitals (Japanese), Med Technol, 2024; 52(1): 22-9. PubMed<\/a><\/span>\n<\/li>\n\n\n\n
  11. Piva E, Plebani M. From \u201cpanic\u201d to \u201ccritical\u201d values: which path toward harmonization? Clin Chem Lab Med. 2013 Nov; 51(11): 2069-71.PubMed<\/a><\/span>\n<\/li>\n\n\n\n
  12. Lippi G, Mattiuzzi C. Critical laboratory values communication: summary recommendations from available guidelines, Ann Transl Med. 2016; 4(20): 400.PubMed<\/a><\/span>\n<\/li>\n\n\n\n
  13. Doering TA, Plapp F, Crawford JM. Establishing evidence base for critical laboratory value thresholds. Am J Clin Pathol. 2014; 142(5): 617-28.PubMed<\/a><\/span>\n<\/li>\n\n\n\n
  14. Murakami Y, Nishikawa M. Current Status and Challenges of Panic Value Reporting. JJSLM. 2021; 69(12): 937-40.<\/li>\n\n\n\n
  15. Meng QH, Wagar EA. Pseudohyperkalemia: a new twist on an old phenomenon. Crit Rev Clin Lab Sci. 2015; 52(2): 45-55. PubMed<\/a><\/span>\n<\/li>\n\n\n\n
  16. Pronovost P, Berenholtz S, Dorman T, et al. Improving communication in the ICU using daily goals. J Crit Care. 2003; 18(2): 71-5.PubMed<\/a><\/span>\n<\/li>\n\n\n\n
  17. Fazzini B, McGinley A, Stewart C. A multidisciplinary safety briefing for acutely ill and deteriorating patients: A quality improvement project. Intensive Crit Care Nurs. 2023; 74: 103331.PubMed<\/a><\/span>\n<\/li>\n<\/ol>\n\n\n\n

    This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).<\/p>\n\n\n\n

    Supplemental figure<\/strong><\/h2>\n\n\n\n
    \"\"<\/figure>\n\n\n\n

    S Figure 1. <\/strong>Example of an actual \u201cphone call record memos\u201d document.<\/p>\n\n\n\n

    \"\"<\/figure>\n\n\n\n

    S Figure 2. <\/strong>The way to manage critical values in our laboratory<\/p>\n\n\n\n

    \"\"<\/figure>\n\n\n\n

    S Figure 3. <\/strong>Monthly number of critical values commenting reports.<\/p>\n\n\n\n

    \"\"<\/figure>\n\n\n\n

    S Figure 4. <\/strong>Transition in the categories of checking telephone calls from laboratory physician.<\/p>\n","protected":false},"excerpt":{"rendered":"

    Ririka Miura*1, Rikei Kozakai*1, Yasuhiro Endo, MD, PhD*1,2, \u2020Shinichiro Takahashi, MD, PhD *1,2 Short Communi […]<\/p>\n","protected":false},"author":1,"featured_media":1974,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"swell_btn_cv_data":"","footnotes":""},"categories":[170,173],"tags":[177],"class_list":["post-1968","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lab-med-int-2025-44","category-short-communication-lab-med-int-2025-44","tag-lab-med-int-2025-444"],"_links":{"self":[{"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/posts\/1968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/comments?post=1968"}],"version-history":[{"count":11,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/posts\/1968\/revisions"}],"predecessor-version":[{"id":2238,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/posts\/1968\/revisions\/2238"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/media\/1974"}],"wp:attachment":[{"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/media?parent=1968"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/categories?post=1968"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lmi.jp\/articles\/wp-json\/wp\/v2\/tags?post=1968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}